CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 78 enrolled
Drug / intervention
Inhaled Nitric Oxide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01939301
NCT01939301Phase 2Completed
CompareCT.gov

Randomized Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism

Indiana University·interventional·Posted Sep 11, 2013·Updated Oct 3, 2018

In Brief

A Phase 2 clinical trial evaluating Inhaled Nitric Oxide and Sham for Pulmonary Embolism. Completed, enrolled 78 participants across 4 sites.

Detailed Summary

This is a randomized study to treat subjects diagnosed with pulmonary embolism with inhaled nitric oxide or placebo (oxygen).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism
CountriesUnited States
CollaboratorsMallinckrodt, National Institutes of Health (NIH), University of Mississippi Medical Center, University of Texas, Southwestern Medical Center at Dallas, National Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 11, 2013
Enrollment StartOct 1, 2013
Primary CompletionOct 31, 2016
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 12.8 years ago

Interventions

Inhaled Nitric Oxidedrug

Nitric Oxide + oxygen

Shamdrug

Nitrogen + Oxygen